The mechanism of phosphorus as a cardiovascular risk factor in CKD
about
Bone morphogenetic protein 7 (BMP7) gene polymorphisms are associated with inverse relationships between vascular calcification and BMD: the Diabetes Heart StudyAlpha Klotho and phosphate homeostasisArterial calcification in chronic kidney disease: key roles for calcium and phosphateCan serum levels of alkaline phosphatase and phosphate predict cardiovascular diseases and total mortality in individuals with preserved renal function? A systemic review and meta-analysisCalcium regulation and bone mineral metabolism in elderly patients with chronic kidney diseaseProtective roles of DMP1 in high phosphate homeostasisThe Phosphate Source Influences Gene Expression and Quality of Mineralization during In Vitro Osteogenic Differentiation of Human Mesenchymal Stem CellsGenetics in arterial calcification: pieces of a puzzle and cogs in a wheel.Ethnic differences in the relationship between albuminuria and calcified atherosclerotic plaque: the African American-diabetes heart study.Association of dietary phosphorus intake and phosphorus to protein ratio with mortality in hemodialysis patients.A randomized, double-blind, placebo-controlled trial of calcium acetate on serum phosphorus concentrations in patients with advanced non-dialysis-dependent chronic kidney diseaseThe association of bone density and calcified atherosclerosis is stronger in women without dyslipidemia: the multi-ethnic study of atherosclerosis.No independent association of serum phosphorus with risk for death or progression to end-stage renal disease in a large screen for chronic kidney disease.CKD-induced wingless/integration1 inhibitors and phosphorus cause the CKD-mineral and bone disorder.Calpain 1 inhibitor BDA-410 ameliorates α-klotho-deficiency phenotypes resembling human aging-related syndromes.Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease.Impact of poverty on serum phosphate concentrations in the Third National Health and Nutrition Examination Survey.Pharmacology, efficacy and safety of oral phosphate binders.Is serum phosphorus control related to parathyroid hormone control in dialysis patients with secondary hyperparathyroidism?Prevalence and prognostic significance of renal artery calcification in patients with diabetes and proteinuriaLow socioeconomic status associates with higher serum phosphate irrespective of raceKlotho deficiency causes vascular calcification in chronic kidney disease.The relation between serum phosphorus levels and clinical outcomes after acute myocardial infarctionCurrent usage and future directions for the bovine pericardial patchPhosphorus binders and survival on hemodialysis.Direct effects of phosphate on vascular cell function.Serum phosphate as a risk factor for cardiovascular events in people with and without chronic kidney disease: a large community based cohort study.The roles of the skeleton and phosphorus in the CKD mineral bone disorderThe dualistic role of vitamin D in vascular calcificationsRelationships between calcified atherosclerotic plaque and bone mineral density in African Americans with type 2 diabetesAssociation of serum phosphorus variability with coronary artery calcification among hemodialysis patients.Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in vitro.Clinical management of disturbances of calcium and phosphate metabolism in dialysis patients.Cardiovascular risk factors in chronic kidney disease: does phosphate qualify?Metabolic abnormalities, cardiovascular disease risk factors, and GFR decline in children with chronic kidney diseaseInteraction of time-varying albumin and phosphorus on mortality in incident dialysis patients.Familial clustering of risk factors for cardiovascular disease among first-degree relatives of patients with chronic kidney disease in a sub-Saharan African population.Phosphorus ingestion improves oral glucose tolerance of healthy male subjects: a crossover experimentSocio-Economic Factors, Food Habits and Phosphorus Levels in Patients on Hemodialysis.Cobrotoxin from Naja naja atra Venom Ameliorates Adriamycin Nephropathy in Rats.
P2860
Q24655399-06C6BB52-163A-40BC-BB10-E82BD3A54225Q26825471-B7C60D24-01B9-4216-9FFA-207542DB24B2Q26827655-399B00FE-CE9E-4DD9-A196-7D00C9DCC292Q26851216-21ED74D9-4395-411B-9405-B574D8B3929BQ26863412-9E111BE0-652D-434F-AA17-C5C29CACBD54Q27325653-10125C71-19BF-4FC7-853E-25441E232D44Q28534068-B98E7751-C04B-4BA9-B2C0-BF12CABACD97Q33352008-BD34099B-4E79-462B-9564-4411986318DFQ33556730-E463F200-46FB-4264-8F3A-78CBF7AC089DQ33769983-50A47D6D-0656-442F-BB96-8E4B34BA1E20Q33821566-33164CB4-FF0F-4DD2-8D04-D8C9531F17F8Q33909059-A830355C-F87B-4D70-817A-25D44F17DE8CQ33920648-6F1242E0-C720-4616-BFD7-E27DD58BFEE2Q33974636-100B7393-D09E-4987-A54B-1B18D675818EQ33986838-44564E0C-17C8-477F-952B-D871E7F4C373Q34017373-D22C37C4-9734-4EF0-85E8-5F9DAB430288Q34118315-38C14ED2-2A61-44AA-9B23-604DB795893DQ34213752-8B049A80-2882-4ACB-BD6D-5397177099CEQ34366087-1F7531C6-060A-464E-9EC4-D32F9648CF39Q34405315-E7834D5B-E28F-477F-AC0B-B8B518BC808DQ34457072-B3DDDD78-2A88-4A42-B8BB-14D02A851289Q34457281-558BD66D-AB6C-4804-96A3-B0E52FEC13C9Q34625745-235F1123-FF51-430C-AB94-7C48FD19D8ABQ34899672-53E08E45-1D43-4B18-95F7-947F6D29B232Q34907022-D00E2141-77D8-4497-A393-71CFA80233DAQ34910006-8C1E31A5-DCA1-4003-A49E-A1612BA3FAD7Q34990456-3B09F9B3-6D5F-45AB-AF65-0EF1AE239DA5Q35013304-43DF57AA-904D-43D3-AE24-B087295EF3A4Q35059753-34ACD9BA-131F-4E8D-AB4C-7991FE60E551Q35124563-ABD74EF6-FD10-4F19-9A52-B0D3ABAE5928Q35152692-110A42F2-1C15-4190-AE9B-D74D98A305D1Q35415040-C3C5928D-F986-4549-92FF-BA74EA95FFCCQ35573785-E6A0F3D5-41EA-4C83-810A-63FE8DE9F5D8Q35679887-43C34D3E-66A5-4DAA-9284-0B86B8010095Q35983445-124E9DD0-3626-4EA4-A50D-9FB44A5091DFQ35985866-5E8393F5-9B05-4A4C-995B-791A2423A4B9Q35990779-A3DD714C-1776-4836-857E-80505F84A283Q36233027-499BAA84-193F-4F4E-914D-CFF6A57F424EQ36234712-9059CEE3-200B-4B61-9DDB-D1E0D9E21BB7Q36316206-A661BA4B-A0A6-4565-A192-3F69E5C73440
P2860
The mechanism of phosphorus as a cardiovascular risk factor in CKD
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
The mechanism of phosphorus as a cardiovascular risk factor in CKD
@ast
The mechanism of phosphorus as a cardiovascular risk factor in CKD
@en
type
label
The mechanism of phosphorus as a cardiovascular risk factor in CKD
@ast
The mechanism of phosphorus as a cardiovascular risk factor in CKD
@en
prefLabel
The mechanism of phosphorus as a cardiovascular risk factor in CKD
@ast
The mechanism of phosphorus as a cardiovascular risk factor in CKD
@en
P2093
P2860
P356
P1476
The mechanism of phosphorus as a cardiovascular risk factor in CKD
@en
P2093
Keith A Hruska
Kimberly S Tustison
Lala R Chaudhary
Leonard Rifas
Suresh Mathew
Toshifumi Sugatani
P2860
P304
P356
10.1681/ASN.2007070760
P577
2008-04-16T00:00:00Z